Hyundai Bio, Lee Ji-eun appointed as Managing Director of Overseas Development and Strategic Marketing


Hyundai Bioscience (CEO Jin Geun-woo) has hired Lee Ji-eun, a marketing strategy expert with over 20 years of experience at domestic and global pharmaceutical companies including Novartis Korea and Hanmi Pharmaceutical, as Managing Director of Overseas Development and Strategic Marketing.

The new Managing Director, Lee Ji-eun, graduated from Chung-Ang University’s Department of Chemistry and Yonsei University’s Graduate School of Business (MBA). She is a marketing strategy expert with diverse experience and practical work in charge of anticancer drugs, rare diseases, and new product launches at domestic companies such as Hanmi Pharmaceutical and Yuhan Pharmaceutical, and global pharmaceutical companies such as Novartis Korea, Mundipharma Korea, and Takeda Pharmaceutical.

To create a smooth environment for Hyundai Bio's overseas business, Lee Sang-moo will be in charge of overseas business development and global marketing strategies, and will be in charge of anticancer platform technology and antiviral commercialization.


  • See more related articles